Sysnav Healthcare is thrilled to be participating in the upcoming Rare Disease Endpoint Advancement Pilot Program Workshop, hosted by the Duke-Margolis Center for Health Policy in collaboration with the FDA.

This event will address the significant unmet medical needs of the 30 million people affected by rare diseases in the United States and facilitate the development of efficacy endpoints for rare disease treatments.

Sysnav Healthcare’s director Damien Eggenspieler will share his perspective on how to leverage digital health technology (DHT) to develop rare disease endpoints.

Save the date: June 7-8, 2023.
Register now at